8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Mar 28, 2024 · 2y ago · Accession 0001517022-24-000031
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Mar 28, 2024
- Report date
- Mar 27, 2024
- Document
- akba-20240327.htm
- Size
- 1.3 MB